Acquiring Company
Impact BioMedical
Acquired Company
Zoar Ltd
West HenriettaBiotechnologyHealth CareBiotechnologyHealth CareDescription
Impact Biomedical Inc. has announced a merger with Zoar Limited, enabling stockholders to exchange shares at a 1:1 ratio post-reverse stock split. This merger focuses on enhancing pharmaceutical capabilities. The transaction, pending approval, aims to develop specialized therapeutic areas. A reverse stock split will precede the merger to consolidate shares.
Quick answer
Impact BioMedical is acquiring Zoar Ltd, announced June 23, 2025. Impact BioMedical is based in West Henrietta, New York, United States.
- How much did Impact BioMedical pay for Zoar Ltd?
- The deal value was not disclosed.
- What does Impact BioMedical do?
- Impact BioMedical Inc. operates in the biotechnology sector, focusing on the development and commercialization of innovative biohealth solutions.
- Where are Impact BioMedical and Zoar Ltd based?
- Impact BioMedical is based in West Henrietta, New York, United States.
- Who are the decision-makers at Impact BioMedical?
- Fundz holds 1 contact at Impact BioMedical. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Biotechnology and Health Care
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Supernus acquires SAGE Therapeutics for USD 8.50/share (July 31, 2025)
- Lantheus Holdings completes acquisition of Life Molecular (July 27, 2025)
- OSR Holdings to acquire Woori IO for healthcare innovation (July 24, 2025)
- AbbVie to acquire Capstan Therapeutics (July 15, 2025)
- Teleflex finalizes acquisition of Biotronik's business (July 2, 2025)
- Galenica acquires Labor Team for diagnostics expansion (July 2, 2025)
Who to call at Impact BioMedical, and when
When Impact BioMedical changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Impact BioMedical raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Impact BioMedical, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Impact BioMedical. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Impact BioMedical makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Zoar Ltd?
Zoar Ltd was acquired by Impact BioMedical, based in West Henrietta. The deal was reported on June 23, 2025. Impact BioMedical Inc. operates in the biotechnology sector, focusing on the development and commercialization of innovative biohealth solutions. Impact BioMedical is publicly traded (IBO) and operates in Biotechnology.
When did Impact BioMedical acquire Zoar Ltd?
Impact BioMedical's acquisition of Zoar Ltd was reported on June 23, 2025. Impact Biomedical Inc. has announced a merger with Zoar Limited, enabling stockholders to exchange shares at a 1:1 ratio post-reverse stock split. This merger focuses on enhancing pharmaceutical capabilities. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Zoar Ltd do?
Zoar Ltd. specializes in the production of pharmaceutical ingredients and intermediates. The company is poised to contribute expertise in human health and wellness markets. It has significant intellectual property in its field. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.